Background Aneurysm rebleeding has historically been an important cause of mortality after
subarachnoid hemorrhage (SAH). Objective To describe the frequency and impact of …

Background— Cardiac troponin I (cTI) release occurs frequently after subarachnoid
hemorrhage (SAH) and has been associated with a neurogenic form of myocardial injury. The …

Background and Purpose— Phenytoin (PHT) is routinely used for seizure prophylaxis after
subarachnoid hemorrhage (SAH), but may adversely affect neurologic and cognitive recovery…

Objective: To compare the efficacy of a novel water-circulating surface cooling system with
conventional measures for treating fever in neuro-intensive care unit patients. Design: …

The neurointensive care management of vasospasm after subarachnoid hemorrhage has
evolved significantly over the past 10 years, with many new diagnostic modalities and …

Background and Purpose— Few pediatric reports of thrombolysis exist. We sought to determine
national rates of thrombolysis among pediatric ischemic stroke patients using a national …

Objective: Early neurologic deterioration has been studied in patients with intracerebral
hemorrhage during hospitalization, but rates and factors associated with prehospital neurologic …

Objective To describe the feasibility and safety of transradial access (TRA) in the interventional
management of acute ischemic stroke (AIS). Methods A retrospective review of the local …

Background Recent studies comparing the outcomes of wake-up stroke (WUS) and stroke
while awake (SWA) patients reveal better outcomes among SWA patients, attributable in part …

OBJECTIVE: Hydroxymethylglutaryl coenzyme A reductase inhibitors (statins), which exhibit
beneficial cerebrovascular effects by modulating inflammation and nitric oxide production, …